Lilly Asia Ventures
Venture Capital
Lilly Asia Ventures (LAV), founded in 2008, is Eli Lilly's corporate VC arm investing in life sciences, healthcare, biotech across Asia and the US.
Shanghai, China · 42+ investments
Seed
Biotech
Healthcare
Life Sciences
- Headquarters
- Shanghai, China
- Founded
- 2008
- Website
- lillyasiaventures.com
- AUM
- $1.2B
- Total Investments
- 42
- Last Investment
- Apr 2026
- Geographic Focus
- Asia, China, United States
Investment Thesis
Long-term growth investments in biomedical and healthcare innovations, focusing on oncology, IoT, manufacturing in China and Asia-Pacific.
Lilly Asia Ventures is a Venture Capital firm based in Shanghai, China. It has made 42 investments in Biotech and Healthcare.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.